| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―06 |
Functional characterization of spike RBD mutations in SARS-CoV-2 Omicron-derived subvariants KP.3.1.1, LP.8.1, and NB.1.8.1. |
Yeong Jun Kim, Seon Jae Jeong, Hye-Ra Lee |
| 2 |
[GO] |
2026―Feb―25 |
Armored RNA technology as a clinical diagnostics tool for future pandemic preparedness |
Jin Hao Tan, Prashant Mainali, Wei Zhang, Dave Siak-Wei Ow |
| 3 |
[GO] |
2025―Jul―21 |
Efficient and modular reverse genetics system for rapid generation of recombinant severe acute respiratory syndrome coronavirus 2 |
Sojung Bae, Jinjong Myoung |
| 4 |
[GO] |
2025―May―27 |
Antiviral effects of heme oxygenase-1 against canine coronavirus and canine influenza virus in vitro |
Jae-Hyeong Kim, Dong-Hwi Kim, Kyu-Beom Lim, Joong-Bok Lee, Seung-Yong Park, Chang-Seon Song, et al. (+5) Sang-Won Lee, Dong-Hun Lee, Do-Geun Kim, Hun-Young Yoon, In-Soo Choi |
| 5 |
[GO] |
2025―Feb―27 |
Efficiency of reverse genetics methods for rescuing severe acute respiratory syndrome coronavirus 2 |
Chang-Joo Park, Taehun Kim, Seung-Min Yoo, Myung-Shin Lee, Nam-Hyuk Cho, Changhoon Park |
| 6 |
[GO] |
2024―Jul―09 |
Exploring COVID-19 Pandemic Disparities with Transcriptomic Meta-analysis from the Perspective of Personalized Medicine |
Medi Kori, Ceyda Kasavi, Kazim Yalcin Arga |
| 7 |
[GO] |
2024―Jun―25 |
The Role of Extracellular Vesicles in Pandemic Viral Infections |
Woosung Shim, Anjae Lee, Jung-Hyun Lee |
| 8 |
[GO] |
2024―May―23 |
Reverse Zoonotic Transmission of SARS-CoV-2 and Monkeypox Virus: A Comprehensive Review |
Chiranjib Chakraborty, Manojit Bhattacharya, Md. Aminul Islam, Hatem Zayed, Elijah Ige Ohimain, Sang-Soo Lee, et al. (+2) Prosun Bhattacharya, Kuldeep Dhama |
| 9 |
[GO] |
2023―Aug―02 |
Erratum to: Protective and Pathogenic Role of Humoral Responses in COVID-19 |
Uni Park, Nam-Hyuk Cho |
| 10 |
[GO] |
2023―Jun―26 |
Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches |
Hee-Jung Lee, Hanul Choi, Aleksandra Nowakowska, Lin-Woo Kang, Minjee Kim, Young Bong Kim |
| 11 |
[GO] |
2022―Mar―02 |
Protective and pathogenic role of humoral responses in COVID-19 |
Uni Park, Nam-Hyuk Cho |
| 12 |
[GO] |
2022―Mar―02 |
Two years of COVID-19 pandemic: where are we now? |
Jinjong Myoung |
| 13 |
[GO] |
2022―Mar―02 |
Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines |
Heedo Park, Mee Sook Park, Jong Hyeon Seok, Jaehwan You, Jineui Kim, Jeonghun Kim, Man-Seong Park |
| 14 |
[GO] |
2022―Mar―02 |
Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models |
Young-Il Kim, Mark Anthony B. Casel, Young Ki Choi |
| 15 |
[GO] |
2022―Feb―14 |
COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity |
Mi-Hyun Lee, Bum-Joon Kim |
| 16 |
[GO] |
2022―Feb―14 |
T cell responses to SARS-CoV-2 in humans and animals |
Sameer-ul-Salam Mattoo, Jinjong Myoung |
| 17 |
[GO] |
2022―Feb―05 |
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways |
Soo-Jin Oh, Ok Sarah Shin |
| 18 |
[GO] |
2022―Jan―28 |
Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants |
Junsoo Park, Rackhyun Park, Minsu Jang, Yea-In Park, Yeonjeong Park |
| 19 |
[GO] |
2022―Jan―28 |
Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies |
Jung-ah Choi, Jae-Ouk Kim |
| 20 |
[GO] |
2022―Jan―28 |
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2 |
Chulwoo Kim, Jae-Deog Kim, Sang-Uk Seo |
| 21 |
[GO] |
2022―Jan―28 |
Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins |
Na-Eun Kim, Yoon-Jae Song |
| 22 |
[GO] |
2021―Nov―01 |
Phytochemicals for the treatment of COVID-19 |
Erica Españo, Jiyeon Kim, Kiho Lee, Jeong-Ki Kim |
| 23 |
[GO] |
2021―Oct―07 |
Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model |
Eun-Ha Kim, Young-il Kim, Seung-Gyu Jang, Minju Im, Kyeongsoo Jeong, Young Ki Choi, Hae-Jung Han |
| 24 |
[GO] |
2021―Aug―27 |
The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance |
Sandrine M. Soh, Yeongjun Kim, Chanwoo Kim, Ui Soon Jang, Hye-Ra Lee |
| 25 |
[GO] |
2021―Aug―11 |
Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge |
Yaya Zhou, Jianchu Zhang, Dongmei Zhang, Wan-Li Ma, Xiaorong Wang |
| 26 |
[GO] |
2021―Apr―28 |
Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea |
Hye Won Jeong, Hyun-Ha Chang, Eun Ji Kim, Yu Kyung Kim, Se-Mi Kim, Eun-Ha Kim, et al. (+12) Young-Il Kim, Mark Anthony B. Casel, Seong-Gyu Kim, Rare Rollon, Seung-Gyu Jang, Kwang-Min Yu, Hee-Sung Kim, Hee Sue Park, Su-Jin Park, Yong-Dae Kim, Eung-Gook Kim, Young Ki Choi |
| 27 |
[GO] |
2021―Feb―23 |
A comprehensive review of SARS-CoV-2 genetic mutations and lessons from animal coronavirus recombination in one health perspective |
Woonsung Na, Hyoungjoon Moon, Daesub Song |
| 28 |
[GO] |
2020―Sep―29 |
Development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) thermal inactivation method with preservation of diagnostic sensitivity |
Young-Il Kim, Mark Anthony B. Casel, Se-Mi Kim, Seong-Gyu Kim, Su-Jin Park, Eun-Ha Kim, et al. (+3) Hye Won Jeong, Haryoung Poo, Young Ki Choi |
